Healthcare Professionals.

Adverse event reporting and prescribing information can be found at the bottom of the page.

Are you a Healthcare Professional?

No, I am not

IBSA medicines for fertility.

This page is intended for UK healthcare professionals only. Here you will find product information, and a wealth of resources to support your work.

Supply chain ownership.

We have complete ownership and control of our supply chain. By overseeing the entire manufacturing process, we guarantee the highest standards of quality in every product we offer, whilst maintaining surety of supply.

We ensure compliance with the legislation in terms of quality, environment and health, through periodic audit plans carried out within the supply chain, as well as continuous inspections in its production sites.

The inside of an IBSA factory, with a worker in white overalls inspecting a computer terminal.

Our products.

  • Fostimon (Urofollitropin)

    • Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate
    • Controlled ovarian hyperstimulation to induce the development of multiple follicles in ART such as IVF, Gamete Intra-fallopian Transfer and Zygotes Intra-fallopian Transfer
    Two Fostimon product packs, showing 75 IU and 150 IU on a light background
  • Lubion (Progesterone)

    • Luteal support in adults as part of an ART treatment program in infertile women who are unable to use or tolerate vaginal preparations
    The Lubion 25mg product pack on a light background
  • Meriofert (Menotrophin)

    • Ovulation induction: for the induction of ovulation in amenorrhoeic or anovulatory women who have not responded to treatment with clomiphene citrate
    • Controlled ovarian hyperstimulation (COH) within a medically assisted reproduction technology (ART): induction of multiple follicular development in women undergoing assisted reproduction techniques such as in vitro fertilisation (IVF)
    Three Meriofert product packs, showing 75 IU, 150 IU and 900 IU, on a light background
  • Zivafert (Human Chorionic Gonadatrophin)

    • Anovulatory or oligo-ovulatory women to trigger ovulation and luteinisation induction after simulation of follicle growth
    • ART program such as IVF: triggering of final follicular maturation and luteinisation after simulation of follicle growth
    The Zivafert 5000 IU product pack on a light background

Prescribing Information.

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.

Adverse events should also be reported to IBSA Pharma Ltd on 01923 233466 and medicalinformation.uk@ibsagroup.com.